Over the past few years, GLP-1 receptor agonists such as Mounjaro (tirzepatide) and Ozempic (semaglutide) have transformed the way doctors treat type 2 diabetes and manage obesity. These medications have been hailed as “game changers,” not only because they help regulate blood sugar but also because they have shown impressive benefits in weight reduction and cardiovascular protection.

But with this popularity has come a flood of myths, misconceptions, and half-truths. Patients often come to consultations with questions shaped more by what they’ve read on social media than by medical science. Some think these medications are miracle weight loss injections. Others believe they are safe for everyone, or that once you achieve weight loss, you can stop them without consequences.

At Moolchand, we believe in giving patients clear, accurate, and compassionate guidance. Under the leadership of Dr. Bhawna Attri, Eminent Endocrinologist trained at the prestigious AIIMS New Delhi, our approach is built on five values that patients can always count on: Superb endocrinologists, Cutting-edge technology, Compassionate care, Integrity, and Affordable prices. With this foundation, let us separate the myths from the facts about GLP-1 therapies so that you can make informed decisions about your health.

What Are GLP-1 Receptor Agonists?

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone in the body. This hormone helps regulate blood sugar by increasing insulin secretion when glucose levels rise, slowing stomach emptying, and reducing appetite. GLP-1 receptor agonists are medications designed to mimic this hormone, giving patients more effective blood sugar control while also contributing to weight loss.

Medications such as Ozempic and Mounjaro fall into this class. While Ozempic primarily targets the GLP-1 pathway, Mounjaro has dual activity (GLP-1 and GIP receptor agonist), which may explain its additional benefits in weight management.

These medicines are usually given as weekly injections and have shown excellent outcomes in lowering blood sugar levels, reducing the risk of cardiovascular events, and helping patients achieve significant weight reduction. Importantly, they can also be prescribed to non-diabetic patients who struggle with obesity or metabolic health issues, under the careful supervision of an endocrinologist like Dr. Bhawna Attri.

Myth vs Fact: GLP-1 Based Therapies

 Myth 1: These are just “weight loss injections.”

 Fact: GLP-1 receptor agonists were originally designed for the treatment of type 2 diabetes, with blood sugar control as their primary goal. Weight loss is a very welcome side effect, but it is not the only or even the main reason they are prescribed.

 Myth 2: Anyone can take these medicines safely.

 Fact: These therapies require careful patient selection. They are not suitable for everyone. People with certain medical histories — such as a family or personal history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or past episodes of pancreatitis — may not be candidates. Only an expert like Dr. Bhawna Attri can decide if you are an appropriate candidate.

 Myth 3: You can stop once you’ve lost weight or feel better.

 Fact: Like most long-term therapies for chronic conditions, GLP-1 medications are often required for extended use. Stopping suddenly, without a proper plan, can cause rebound weight gain or worsening blood sugar control.

 Myth 4: Medication replaces lifestyle changes.

 Fact: GLP-1 therapies are not shortcuts. They are most effective when paired with healthy eating, physical activity, sleep hygiene, and behavioral support.

Why Expert Guidance Matters

GLP-1 therapies are powerful but not one-size-fits-all. Just as every patient is unique, the way these medicines are prescribed, monitored, and adjusted must also be personalized.

At Moolchand, Dr. Bhawna Attri, an eminent endocrinologist trained from AIIMS New Delhi, carefully evaluates your medical history, lifestyle, and health goals before recommending GLP-1 therapy. Using cutting-edge technology, including advanced diagnostics and digital patient monitoring, she and her team tailor the treatment to your specific needs.

Here’s what expert endocrinologist guidance ensures:

1. Proper Screening: Identifying whether you are a safe candidate for GLP-1 therapy.

2. Personalized Dosing: Adjusting the dosage to maximize benefits while minimizing side effects.

3. Side Effect Monitoring: Keeping track of common effects like nausea or constipation, and managing them effectively.

4. Integrated Care: Aligning your therapy with nutrition, exercise, and mental wellbeing.

5. Sustainability: Helping you achieve results that last, rather than short-term gains.

Above all, you can trust that at Moolchand, your care is guided by integrity — meaning we will never recommend a therapy unless it is truly right for you. And with our commitment to affordable prices, world-class care remains accessible.

Patient-Centered Care at Moolchand

What sets Moolchand apart is not only our expertise but also the way we deliver care. We believe in compassionate care — listening to patients, respecting their concerns, and supporting them at every step of the journey.

A patient considering Mounjaro or Ozempic at Moolchand will not only meet with Dr. Bhawna Attri but will also receive counseling from nutritionists, support from nurses, and guidance on lifestyle changes. We work as a team to ensure your therapy is safe, effective, and sustainable.

Our patients often tell us that the difference lies in how we treat them — not just with medicines, but with empathy, patience, and honesty. This is where our superb endocrinologists truly shine, combining world-class knowledge with a human touch.

Looking Ahead: The Future of GLP-1 Therapy

Research on GLP-1 receptor agonists continues to grow. Recent studies suggest benefits beyond diabetes and weight management, including potential roles in heart disease prevention, fatty liver disease, and even neurological conditions.

For now, what matters most is that patients understand both the opportunities and the limitations of these therapies. They are not fads or quick fixes; they are part of a broader medical strategy to manage chronic disease and improve quality of life.

At Moolchand, under the guidance of Dr. Bhawna Attri, we ensure patients have access to the latest treatments, supported by science, compassion, and trust.

Final Word

GLP-1 therapies such as Mounjaro and Ozempic are changing lives. But like any powerful medical treatment, they come with responsibilities — to use them wisely, under expert guidance, and as part of a holistic approach to health.

At Moolchand, we make this journey safe and effective through our values: Superb endocrinologists, Cutting-edge technology, Compassionate care, Integrity, and Affordable prices. These aren’t just words — they are the pillars of the trust generations of patients have placed in us.

 If you’re considering GLP-1 therapy, consult with Dr. Bhawna Attri, Eminent Endocrinologist trained from AIIMS New Delhi, at Moolchand. Let her guide you toward sustainable, science-based, and compassionate care for your long-term health.